On Tuesday, Bausch + Lomb Corp (NYSE: BLCO) opened lower -5.08% from the last session, before settling in for the closing price of $12.20. Price fluctuations for BLCO have ranged from $10.45 to $21.69 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 4.87%. Company’s average yearly earnings per share was noted -28.63% at the time writing. With a float of $36.48 million, this company’s outstanding shares have now reached $353.36 million.
Let’s determine the extent of company efficiency that accounts for 13500 employees. In terms of profitability, gross margin is 56.97%, operating margin of 1.8%, and the pretax margin is -6.72%.
Bausch + Lomb Corp (BLCO) Insider Activity
A key investor’s attitude towards the stock of the Medical Instruments & Supplies industry is another important factor to consider. The insider ownership of Bausch + Lomb Corp is 89.68%, while institutional ownership is 9.85%. The most recent insider transaction that took place on May 22 ’25, was worth 248,072. In this transaction CEO and Chairman of the Board of this company bought 22,000 shares at a rate of $11.28, taking the stock ownership to the 719,156 shares. Before that another transaction happened on May 02 ’25, when Company’s Director bought 1,695 for $11.76, making the entire transaction worth $19,925. This insider now owns 41,748 shares in total.
Bausch + Lomb Corp (BLCO) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -28.63% per share during the next fiscal year.
Bausch + Lomb Corp (NYSE: BLCO) Trading Performance Indicators
Check out the current performance indicators for Bausch + Lomb Corp (BLCO). In the past quarter, the stock posted a quick ratio of 0.96. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.85.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.03, a number that is poised to hit 0.07 in the next quarter and is forecasted to reach 0.77 in one year’s time.
Technical Analysis of Bausch + Lomb Corp (BLCO)
Looking closely at Bausch + Lomb Corp (NYSE: BLCO), its last 5-days average volume was 0.62 million, which is a drop from its year-to-date volume of 0.76 million. As of the previous 9 days, the stock’s Stochastic %D was 48.09%. Additionally, its Average True Range was 0.46.
During the past 100 days, Bausch + Lomb Corp’s (BLCO) raw stochastic average was set at 14.69%, which indicates a significant decrease from 24.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.59% in the past 14 days, which was lower than the 58.66% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.91, while its 200-day Moving Average is $16.35. However, in the short run, Bausch + Lomb Corp’s stock first resistance to watch stands at $11.96. Second resistance stands at $12.34. The third major resistance level sits at $12.54. If the price goes on to break the first support level at $11.38, it is likely to go to the next support level at $11.18. Should the price break the second support level, the third support level stands at $10.80.
Bausch + Lomb Corp (NYSE: BLCO) Key Stats
There are currently 353,721K shares outstanding in the company with a market cap of 4.09 billion. Presently, the company’s annual sales total 4,791 M according to its annual income of -317,000 K. Last quarter, the company’s sales amounted to 1,137 M and its income totaled -212,000 K.
